Search Results - "Willeit, Peter"

Refine Results
  1. 1

    Environmental toxic metal contaminants and risk of cardiovascular disease: systematic review and meta-analysis by Chowdhury, Rajiv, Ramond, Anna, O’Keeffe, Linda M, Shahzad, Sara, Kunutsor, Setor K, Muka, Taulant, Gregson, John, Willeit, Peter, Warnakula, Samantha, Khan, Hassan, Chowdhury, Susmita, Gobin, Reeta, Franco, Oscar H, Di Angelantonio, Emanuele

    Published in BMJ (Online) (29-08-2018)
    “…ABSTRACTObjectiveTo conduct a systematic review and meta-analysis of epidemiological studies investigating the association of arsenic, lead, cadmium, mercury,…”
    Get full text
    Journal Article
  2. 2

    Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease? by Willeit, Peter, Skroblin, Philipp, Kiechl, Stefan, Fernández-Hernando, Carlos, Mayr, Manuel

    Published in European heart journal (14-11-2016)
    “…Recent discoveries have revealed that microRNAs (miRNAs) play a key role in the regulation of gene expression. In this review, we summarize the rapidly…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Lipidomics Profiling and Risk of Cardiovascular Disease in the Prospective Population-Based Bruneck Study by Stegemann, Christin, Pechlaner, Raimund, Willeit, Peter, Langley, Sarah R, Mangino, Massimo, Mayr, Ursula, Menni, Cristina, Moayyeri, Alireza, Santer, Peter, Rungger, Gregor, Spector, Tim D, Willeit, Johann, Kiechl, Stefan, Mayr, Manuel

    Published in Circulation (New York, N.Y.) (06-05-2014)
    “…BACKGROUND—The bulk of cardiovascular disease risk is not explained by traditional risk factors. Recent advances in mass spectrometry allow the identification…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes by Zampetaki, Anna, Kiechl, Stefan, Drozdov, Ignat, Willeit, Peter, Mayr, Ursula, Prokopi, Marianna, Mayr, Agnes, Weger, Siegfried, Oberhollenzer, Friedrich, Bonora, Enzo, Shah, Ajay, Willeit, Johann, Mayr, Manuel

    Published in Circulation research (17-09-2010)
    “…RATIONALE:MicroRNAs (miRNAs) have been implicated in the epigenetic regulation of key metabolic, inflammatory, and antiangiogenic pathways in type 2 diabetes…”
    Get full text
    Journal Article
  7. 7
  8. 8

    The interconnection between lipoprotein(a), lipoprotein(a) cholesterol and true LDL-cholesterol in the diagnosis of familial hypercholesterolemia by Yeang, Calvin, Willeit, Peter, Tsimikas, Sotirios

    Published in Current opinion in lipidology (01-12-2020)
    “…Elevated levels of lipoprotein(a) [Lp(a)] are present in 30-50% of patients with familial hypercholesterolemia. The contribution of Lp(a) towards risk…”
    Get full text
    Journal Article
  9. 9

    Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants by Tschiderer, Lena, Willeit, Johann, Schett, Georg, Kiechl, Stefan, Willeit, Peter

    Published in PloS one (24-08-2017)
    “…Recent experimental and epidemiological studies have suggested that osteoprotegerin, a key regulator in bone metabolism, may be involved in vascular…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Breastfeeding Is Associated With a Reduced Maternal Cardiovascular Risk: Systematic Review and Meta-Analysis Involving Data From 8 Studies and 1 192 700 Parous Women by Tschiderer, Lena, Seekircher, Lisa, Kunutsor, Setor K, Peters, Sanne A E, O'Keeffe, Linda M, Willeit, Peter

    Published in Journal of the American Heart Association (18-01-2022)
    “…Background Breastfeeding has been robustly linked to reduced maternal risk of breast cancer, ovarian cancer, and type 2 diabetes. We herein systematically…”
    Get full text
    Journal Article
  14. 14

    MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery by Mayr, Manuel, Zampetaki, Anna, Willeit, Peter, Willeit, Johann, Kiechl, Stefan

    “…The postgenomic shift in paradigm from reductionism to systems-wide network inference has increased recognition that cardiovascular diseases are not simply…”
    Get full text
    Journal Article
  15. 15

    Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population‐based 10‐year study by Mahlknecht, Philipp, Gasperi, Arno, Djamshidian, Atbin, Kiechl, Stefan, Stockner, Heike, Willeit, Peter, Willeit, Johann, Rungger, Gregorio, Poewe, Werner, Seppi, Klaus

    Published in Movement disorders (01-03-2018)
    “…ABSTRACT Objective: We aimed to identify prodromal Parkinson's disease (PD) and its predictive accuracy for incident PD in an unselected elderly population and…”
    Get full text
    Journal Article
  16. 16

    Leucocyte telomere length and risk of type 2 diabetes mellitus: new prospective cohort study and literature-based meta-analysis by Willeit, Peter, Raschenberger, Julia, Heydon, Emma E, Tsimikas, Sotirios, Haun, Margot, Mayr, Agnes, Weger, Siegfried, Witztum, Joseph L, Butterworth, Adam S, Willeit, Johann, Kronenberg, Florian, Kiechl, Stefan

    Published in PloS one (12-11-2014)
    “…Short telomeres have been linked to various age-related diseases. We aimed to assess the association of telomere length with incident type 2 diabetes mellitus…”
    Get full text
    Journal Article
  17. 17

    Circulating MicroRNAs as Novel Biomarkers for Platelet Activation by Willeit, Peter, Zampetaki, Anna, Dudek, Katarzyna, Kaudewitz, Dorothee, King, Alice, Kirkby, Nicholas S, Crosby-Nwaobi, Roxanne, Prokopi, Marianna, Drozdov, Ignat, Langley, Sarah R, Sivaprasad, Sobha, Markus, Hugh S, Mitchell, Jane A, Warner, Timothy D, Kiechl, Stefan, Mayr, Manuel

    Published in Circulation research (15-02-2013)
    “…RATIONALE:MicroRNA (miRNA) biomarkers are attracting considerable interest. Effects of medication, however, have not been investigated thus far. OBJECTIVE:To…”
    Get full text
    Journal Article
  18. 18

    Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes by Zampetaki, Anna, Willeit, Peter, Burr, Simon, Yin, Xiaoke, Langley, Sarah R, Kiechl, Stefan, Klein, Ronald, Rossing, Peter, Chaturvedi, Nishi, Mayr, Manuel

    Published in Diabetes (New York, N.Y.) (01-01-2016)
    “…Circulating microRNAs (miRNAs) have emerged as novel biomarkers of diabetes. The current study focuses on the role of circulating miRNAs in patients with type…”
    Get full text
    Journal Article
  19. 19
  20. 20